Zinc Sulfate
Zinc sulfate is a mineral supplement belonging to the zinc salt class. It is primarily used to prevent and treat zinc deficiency and support immune function, wound healing, and normal growth and development. It is also used as an adjunct in the treatment of acute diarrhoea in children, particularly in combination with oral rehydration solution (ORS). It works by supplying elemental zinc, which acts as a cofactor for numerous enzymes involved in protein synthesis, DNA synthesis, cell division, and tissue repair. Zinc also supports normal immune responses and intestinal health. Zinc sulfate is available in oral tablet, capsule, syrup, and dispersible tablet forms. Common side effects include nausea, vomiting, abdominal discomfort, diarrhoea, and a metallic taste. Excessive or prolonged use may cause copper deficiency, anaemia, and impaired immune function. Dosage should be based on elemental zinc content, and prolonged supplementation should be medically supervised.
Zinc Sulfate was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Zinc Sulfate, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Zinc Sulfate from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Zinc Sulfate, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
